NARB Recommends that Young Living Essential Oils Discontinue “Therapeutic Grade” and Health and Wellness Benefit Claims

For Immediate Release
Contact: Abby Hills, Director of Communications, BBB National Programs

703-247-9330 / press@bbbnp.org

New York, NY – November 24, 2020 – A panel of the National Advertising Review Board (NARB), the appellate advertising law body of BBB National Programs, has recommended that Young Living Essential Oils, LC (Young Living) discontinue “therapeutic grade” claims for its “essential oils,” as well as unsupported health and wellness benefit claims.

The advertising at issue, as well as other claims, had been challenged by S.C. Johnson & Son, Inc. (SCJ) before the National Advertising Division (NAD) of BBB National Programs. Following NAD’s decision (Case No. 6385), Young Living appealed all aspects of NAD’s findings adverse to it.

Young Living sells “essential oils” (i.e. oils extracted from herbs, flowers, and other plants) online and through a direct-sales network. These products are considered “aromatherapy” alternative-medicine products. Among the key essential oils in Young Living’s aromatherapy products are lavender, Hinoki, Ylang-Ylang, Valerian, bergamot, davana, peppermint, rosemary, and grapefruit. Many of the Young Living products are “blends,” meaning they include two or more essential oils. Wellness benefits referred to in Young Living advertising for one or more of its aromatherapy products include:

  • Promoting feelings of stability and calm
  • Promoting restful sleep
  • Improving clarity, focus, or alertness
  • Improving mood and motivation


All of Young Living’s aromatherapy products (several hundred) are labeled “therapeutic grade.” The NARB panel concluded that the term “therapeutic grade” is unsupported and recommended that it be discontinued. 

  • The panel determined that the health and wellness message conveyed by the term “therapeutic grade” was not supported with the requisite scientific evidence. 
  • The panel concluded that the term “therapeutic grade” conveys the unsupported message that Young Living’s product is rated therapeutic under an existing set of third-party standards for evaluating essential oils. 


The NARB panel also determined that Young Living’s health-related product claims lack proper scientific substantiation and recommended that they be discontinued. 

  • The panel accepted as valid the evidence showing that the chemical make-up/composition of essential oils can vary widely. 
  • The panel noted that Young Living has no information concerning the essential oils used in the published studies it relies on for scientific support for the claimed efficacy of its own products.
  • The panel noted that there was no evidence in the record that blending different essential oils into one product, like Young Living does with its “blends,” does not have an impact on the claimed benefits.


Young Living stated that it will comply with NARB’s decision, but noted that the company disagreed with the legal and factual findings of the original NAD case because, according to Young Living, “NAD only relied on the summaries of the third-party studies submitted as substantiation and did not ask to have the full study reports submitted.” According to Young Living, “without reviewing the complete studies at issue, NAD should not have rejected the relevance of the results in peer reviewed and published studies conducted by extremely well-qualified researchers from institutions such as Wesleyan University and Duke University.”

###

About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. The non-profit organization creates a fairer playing field for businesses and a better experience for consumers through the development and delivery of effective third-party accountability and dispute resolution programs. Embracing its role as an independent organization since the restructuring of the Council of Better Business Bureaus in June 2019, BBB National Programs today oversees more than a dozen leading national industry self-regulation programs, and continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-directed marketing, and privacy. To learn more, visit bbbprograms.org.

About the National Advertising Review Board (NARB): The National Advertising Review Board (NARB) is the appellate body for BBB National Programs’ advertising self-regulatory programs. NARB’s panel members include 87 distinguished volunteer professionals from the national advertising industry, agencies, and public members, such as academics and former members of the public sector. NARB serves as a layer of independent industry peer review that helps engender trust and compliance in NAD, CARU, and DSSRC matters. 

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Dr. Luke Healthcare Discontinue Treatment Claims for its Fungal Nail Renewal Product

New York, NY – July 24, 2024 – The National Advertising Division recommended Dr. Luke Healthcare discontinue certain claims for Dr. Luke’s Fungal Nail Renewal product, including health-related claims, natural claims, and claims that a doctor recommends the product or that it treats a medical condition.

Read the Decision Summary
Decision

National Advertising Division Finds Flag Image on Kendamil Infant Formula Packaging Conveys Supported Message about Products’ Origin

New York, NY – July 17, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division determined that use of a flag image on product packaging for Kendal Nutricare’s Kendamil infant formula reasonably conveys a supported message about the products’ origin. 

Read the Decision Summary
Decision

In National Advertising Division Case, GuruNanda Voluntarily Discontinues Claims Made through Influencers for Coconut Pulling Oil Products

New York, NY – July 16, 2024 – The National Advertising Division has closed a Fast-Track SWIFT challenge regarding claims that GuruNanda’s coconut pulling oil products can “naturally reverse a cavity” and “reverse cavities.” 

Read the Decision Summary
Decision

National Advertising Division Refers Health-Related Advertising Claims for Prolacta’s Human Milk Fortifier to Regulatory Agencies

New York, NY – July 15, 2024 – The National Advertising Division will refer advertising claims made by Prolacta Bioscience for its Human Milk Fortifier to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) for review.

Read the Decision Summary